A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis
Conditions: Allergic Rhinitis Interventions: Drug: azelastine/fluticasone 137/50 mcg nasal spray; Drug: Dymista ™ Sponsors: Synmosa Biopharma Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials

Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Condition:   Bioequivalence Interventions:   Drug: Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals;   Drug: ADVAIR DISKUS® 500/50 Sponsors:   Respirent Pharmaceuticals Co Ltd.;   Becro Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Bioequivalence Study for Fluticasone Propionate 250 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Condition:   Bioequivalence Interventions:   Drug: Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals;   Drug: ADVAIR DISKUS® 250/50 Sponsors:   Respirent Pharmaceuticals Co Ltd.;   Becro Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials